The 'big data revolution' has enabled novel types of analyses in the life sciences, facilitated by public sharing and reuse of datasets. Here, we review the prodigious potential of reusing publicly available datasets and the challenges, limitations and risks associated with it. Due to the prominence, abundance and wide distribution of sequencing results, we focus on the reuse of publicly available sequence datasets. Through selected examples of successful reuse of different data (genome, transcriptome, proteome, metabolome, phenotype and ecosystem), with their respective limitations and risks, we illustrate the enormous potential of the practice. A checklist to determine the reuse value and potential of particular dataset is also provided.
Introduction
The transition from (hand) written notes to datasets stored on hard drives can be viewed as the first step on the road to effective data reuse in the life sciences ( Fig. 1) , allowing the generation of multiple copies at almost no additional cost.
The second step was improved connectivity, which was provided by the internet.
Together, these technological advances in data storage and transfer enabled worldwide exchange of 'big data', which is common in biology (e.g. genomic sequences). The sharing of datasets leads to statistical robustness and allows re-analysis of existing datasets underlying claims (1) while enabling discovery of novel patterns through meta-analysis (2) . Such building on existing knowledge and constant re-examination of prevailing hypotheses is the foundation of the scientific endeavour and is bolstered through 'open science'. To establish data sharing as a norm it had to be introduced through obligations and promoted through benefits (3) for researchers. Numerous funding agencies and publishers (e.g. Nature: (4), NSF: (5) , PLOS: (6) ) require all data be made publicly available within a certain time frame, with an indication that this leads to increased transparency in the field (7) . Dataset sharing may also increase attention to the associated research and resulting in additional citations, an added encouragement for authors (8) . Despite these measures and benefits, an analysis (2017) of 318 biomedical journals revealed that only 11.9% of journals explicitly stated that data sharing was required as a condition of publication (9) .
Many international data sharing guidelines like FAIR (Findable Accessible
Interoperable Reusable) (10) , TOP (The Transparency and Openness Promotion) (11) , Open Data in a Big Data World (1) and the Beijing Declaration (CODATA) (12) have emerged by necessity of the 'big data revolution'. However, if the publicly available datasets are not widely re-examined (either checked for quality or re-analysed), enforcement of open science through policy may not be sufficient to harness the full power of global sharing (13 Besides this ambiguity, the main causes of researchers refraining from reusing publicly available datasets are (i) concern about the quality and reliability of data (often warranted), (ii) a lack of awareness about the potential in big data or (iii) insufficient bioinformatics knowledge to mine the data (14) . Regardless of the cause, a 'backlog' of under-utilised reliable datasets leads to unnecessary experiments (e.g. extensive repetitive sequencing increasing costs) and likely hides useful patterns. Therefore, education about the opportunities, challenges, limitations and techniques of data reuse is a vital task. Here, we highlight hurdles which need to be overcome, point out constraints which must be considered, and give examples of successful data reuse to inform future projects. In addition, we provide a checklist for biologists to aid in determining whether a particular dataset is fit for reuse.
Types of reusable data
There are numerous different types of datasets which harbour reuse potential sequences of genomes, single genes or plasmids or whole sets of sequence reads, 3: annotations of sequences e.g. plasmid maps, sequence motifs e.g. collected in JASPAR (http://jaspar.genereg.net/), 4: chromatography results and mass spectra, 5: information about the structure of proteins, 6: biochemical parameters of enzymes e.g. affinity or speed, 7: geo data e.g. coordinates of observations, 8: images of biological material or geographical regions or 9:
phenotypic data e.g. collected in the plant genomics and phenomics research data repository (PGP) using the e!DAL software infrastructure (15). Generally, datasets can be classified as primary and derived. One example is the famous eGFP browser which provides the content of RNA-Seq datasets in a simple way to biologists. The alternative would be downloading and analysing raw RNA-Seq datasets from the Sequence Read Archive (SRA) which would require a substantial amount of bioinformatic expertise and computational power during the analysis. Valuable computational resources are provided by international and national cloud computing services like Elixir, CyVerse or the German Network for Bioinformatics Infrastructure (de.NBI) as well as by commercial organizations.
Further, it has to be considered that specific fields require the integration of data of various types, formats and abundance (21) which is hard to realise by a single database and therefore requires cooperation to encourage data reuse. Here, we focus on the reuse of primary data, specifically different sequences as the data type characteristic of the life sciences and continuously producing vast amounts of information.
Potential of reusing public datasets
There are numerous advantages of making data publicly available for reuse including reduction of costs, reproduction and accountability of research, enabled discovery of additional scientific knowledge, and detection of novel biological information (13, 21, 22) . While the scientific community and society is profiting most from public datasets, there are additional well documented benefits of open access for authors themselves (e.g. increase in attention and ultimately citations) (3, 23, 24) . Researchers can build a reputation by generating high quality and well documented datasets. Further, the publication of data not only contributes to the advancement of the scientific community but can additionally be helpful for other areas like education or business (13) . These benefits for individuals and the scientific community as a whole make a strong case for the obligation to reuse data whenever that is appropriate.
Preventing information loss
Making data publicly available is an elegant way to prevent information loss resulting from underexamined data stored on various servers. Moreover, the development of new tools and methods leads to the possibility of extracting more information from a given dataset than was feasible at the time of publication. An outstanding example is the basecalling step when working with nanopore sequencing data derived from Oxford Nanopore Technologies (ONT) devices.
Enhanced algorithms allow higher accuracy or even the identification of DNA modifications (25, 26) . Further, meta-analyses like the prediction of specific genomic features together with machine learning approaches require large amounts of data which are already available and therefore should not and cannot 7 be produced once again. There are already many public repositories for genomic and gene-expression data like the SRA / European Nucleotide Archive (ENA) and Gene Expression Omnibus (GEO), respectively. However, the low availability of metadata in standardized formats with sufficient additional information leads to a lack of reproducibility (27) .
Benefits for databases
The reuse of sequence data is of increasing importance due to the large and still rapidly growing size of the corresponding databases ( Fig. 3 ). The size of the SRA alone increased from 3,092,408 entries to 6,243,265 entries within two years (September 2016 -September 2018) (28, 29) and this growth rate continues to increase exponentially. GenBank comprises a total of 3,677,023,810,243 sequences (2018) with an increase of 39,52 % in comparison to 2017 (30) . Approximately 120 million sequences and annotations of proteins were available within UniProtKB/TrEMBL in 2018 (31). The increasing size of scientific data is a challenge for the databases regarding e.g. storage space and data management. However, reusing available data instead of producing new and redundant datasets results in a lower amount of duplicates and keeps databases concise. The public availability of datasets also allows the development of effective algorithms to tackle the bottleneck of data processing, all without the need to perform any sequencing (i.e. uncoupling the problem from access to sequence technology and allowing participation of e.g. computational fields). Additionally, not only the storage of a large number of datasets but also the actual reuse of the available data might increase funding of public databases and therefore ensure the long-term existence of these infrastructures.
Challenges, limitations and risks of data reuse and possible solutions
As discussed above, open access to datasets and studies would accelerate science while being cost-efficient (32) . However, the open access to data would require appropriate quality of the data in order to be reliable for the user which the peer review process can hardly accomplish. This is especially a problem for clinical trials as the results could have a direct impact on the patients involved.
Therefore, it is important that the limitations of particular datasets are identified and the associated risks assessed.
Unknown quality
Quality differences are a big issue when reusing public data. Mislabelled or swapped samples alongside intrinsic errors, like missing technical replicates, can be a problem as they are almost impossible to identify. Further, there are quality differences between user-submitted public datasets, very curated databases for specific organisms, ones with inherently small holding size (like PDB or SwissProt) and phenotype databases. Moreover, simply using a large amount of publicly available datasets does not inherently lead to correct patterns.
Despite the importance of trends revealed from large datasets, it is not always the case that a large number of reads/replicates with low noise means that the emerging results are true. Indeed, one can imagine a large dataset trend with low noise produced when one author/group is responsible for most of the data and a systematic error is present and so there is low deviation. On the other end of the spectrum, the use of a small dataset that is believed to be of "higher quality" and leads to low noise, may hide a novel pattern or even show a nonexisting one.
Information regarding experimental design, methods and conditions is often insufficient and results in datasets unsuitable for reuse. However, additional requirements for data submission should not result in fewer publicly available datasets (27) . There is a trade-off between the collection of detailed metadata during submission and high submission numbers. Many sequence databases like ENA are handling this elegantly. Submitting users can provide a very basic set of meta information or provide comprehensive details about their study.
There are also easy to follow instructions for the submission process (33) .
Denormalisation
Of particular concern is the circular reuse of data which can, for example, lead to a heavily denormalised annotation in databases (34) with the same data being stored multiple times in the same database, without that reflecting the true data distribution (e.g. sequencing and annotation errors propagated by reuse and not eliminated by additional published sequences that would show it to be statistically insignificant). For annotations, it has been shown that it is possible to detect low-quality entries, resulting from this denormalisation, by looking for specific patterns of provenance in the database (35) . With respect to gene models, this problem could be addressed in the future through the integration of RNA-Seq datasets in the annotation of new genome sequences. In terms of functional annotations, this issue persists as the experimental characterization of numerous genes in a diverse set of species cannot be expected in the near future.
Comparison and integration of different databases
Further, the comparison and integration of datasets from different sources remains a challenge (13) . Examples are enormous differences in the annotations provided by the different databases e.g. NCBI, ENSEMBL, and phytozome for the same species. For any valid comparison between datasets from different databases or for integration of databases themselves, an established and unified file standard is crucial. FASTA (36) , FASTQ (37) , and SAM/BAM (38) are famous examples of file standards that allowed effective exchange of information between numerous groups involved in the earliest sequencing projects (39) (40) (41) .
Re-analysis and metainformation
Re-analysis can be a way to tackle the issues mentioned above. As with reexamination of public biodiversity data to correct errors (42, 43) , so should sequence repositories reflect changes in the field's consensus (e.g. about specific annotations). This can be achieved through curation and self-correction, with both being difficult to directly re-enforce.
Therefore, a way to reduce some of the risks of reuse would be investing in a controlled environment containing extensively peer-reviewed datasets (32) . The epitome of such databases are 'expression atlases' with manually curated and annotated sequences checked for quality and re-analysed using standardised methods (44) . However, regarding the enormous and still increasing amount of e.g. sequence data, this is hardly an option for all data types. Different strategies might work for different data types or different communities. In all cases, specific standards and formats for data reuse should be applied (13) . And a defined, suitable environment or database could also include follow-up data for a detailed understanding of the primary data and the corresponding results. Ultimately, the limitations of each study (and dataset) are best known by the primary investigators and not by the community accessing the data -a trade-off that studies based on reused data must consider.
Indeed, it is the metadata (information about the acquisition, processing and presentation) published that is of critical importance in checking for quality. Data papers (already common practice in Astronomy (45) have been indicated as a solution to the quality-check problem (46) of reuse by providing descriptions of methods for collecting, processing, and verifying data (13) . Widespread publication of such metadata in data journals (47) is vital to the construction of high quality, peer-reviewed datasets. Consequently, method-focused or datafocused journals, like e.g. BMC Plant Methods, Nature Methods and GigaScience, emerged during the last years.
A dataset cannot be validly reused, if its metadata is not also assessed.
Therefore, 'open science' incentives and database contribution guidelines should require the inclusion of metadata in all submissions to public datasets.
This would not only encourage authors to collect data with reuse in mind (48), but enable productive and valid re-analysis. A reusability score assigned by the community could increase the quality of the provided metadata.
Research integrity considerations
The use of the same dataset in several different studies by the same author could be considered as a type of dual publication (49) . However, such reuse is not contentious to the same extent as plagiarism, if it reveals novel findings and is not only reused to boost the number of publications. To a certain degree, this issue can be tackled with data publications (as is the case with unknown quality) which might also prevent the splitting of a coherent dataset over multiple publications. By providing a citable source of the dataset, credit is given to the data producer, which eliminates the concern about ownership by providing an official academic record of provenance. As long-read sequencing became On the one hand, modern biologists are encouraged to make use of publicly available sequence repositories and mine data generated by others.
Furthermore, there is an argument to be made that data reuse is an obligation; not comparing one's dataset to publicly available analogues is akin to ignoring replicated experiments (14) . This reduces the rate of redundant sequencing and unveils new correlations through meta-analysis. Cutting such costs (50) enables groups with small budgets to harness extensive datasets thus enhancing equality. This especially aids early career researchers, who are outsiders of the scientific establishment and likely experience more barriers to other aspects of open science (51) , yet are highly involved in data collection and analysis (52) .
On the other hand, there appears to be a trend for people to not only supplement their wet lab and sequencing results with publicly available data but to publish almost exclusively from the latter (19, (53) (54) (55) . At the far end of the spectrum there are authors exclusively using publicly available data (not generating their own to cross-check the quality), often choosing research topics/systems of interest based on the quality of data and not vice versa. 'Research parasitism' is associated with numerous advantages like intensified use of existing datasets which effectively increases the ratio of value drawn from it compared to the costs of generating it in the first place. Despite some expressed concerns regarding such 'parasitism' (53) , including the fear of exploitation when acquiring the data was particularly expensive or labour-intensive (51) 
Examples of successful data reuse
There are already numerous examples of successful studies which involved intensive reuse of public datasets. Table 1 shows selected reuse cases to cover many areas and concepts of data reuse sorted by the type of the analysed data.
Genomic data can, for example, be harnessed for pangenomic analyses (56) while transcriptomic and ChIP-seq data might be useful for the investigation or construction of regulatory networks (57) . Phylogenetic analysis of groups from individual gene families (58) to whole taxonomic groups (59) benefits from reuse of genome, transcriptome and proteome data. Further, several tools and techniques have been developed for e.g. mining antimicrobial peptides from public databases (22) . The taxonomic classification of sequences identified in metagenomic studies is another application which heavily relies on available data as the quality scales with quality and size of the available data (60) . It can be expected that machine learning will become ever more ubiquitous in combination with other methods due to its ability to tackle large datasets and reveal novel patterns. (63) Large number of false positives requires large datasets, their sharing and compulsory replication (64) Transcriptome Co-expression analysis to find connected genes, e.g. identification of long non-coding RNAs associated with atherosclerosis progression (65); Co-expression networks, e.g. related to bamboo development using public RNA-Seq data (66) or related to cellulose synthesis using public microarray data (67); Construction of regulatory networks using co-expression data, e.g. coexpression network analysis to reveal genes in growth-defence trade-offs under JA signalling (68) Batch effects if large sample groups come from the same source Gene expression analysis to find/identify best gene candidate for cloning (and select the right tissue), e.g. integration with GWAS to identify causal genes in maize (69) Batch effects if large sample groups come from the same source, success depends on the gene expression data context Identification of qRT-PCR reference genes (70) (71) (72) Batch effects if large sample groups come from the same source Gene prediction via analysis of RNA-Seq data (73) and e.g. GeMoMa is using this heavily (74) Batch effects if large sample groups come from the same source Gene expression web sites, e.g. the eGFP browser (75) Only genes in the annotation included. Only based on the available structural annotation thus alternative transcripts would be missed Analysis of non-canonical splice sites based on genome sequences, annotations, and RNA-Seq datasets (19, 55) Batch effects if large sample groups come from the same source and annotation errors will impact analysis results Extraction of new sequences for phylogenetic analysis (18, 76) Reliability of source is crucial, transcriptome assemblies are inherently incomplete as not all genes are expressed at the same time Proteome Identification of antimicrobial peptides (22) Prediction, correct modelling and structural analysis are not completely accurate due to e.g. the presence of precursors; validation is required Phospho-proteomics, e.g. compartmentalisation of phosphorylation motifs (77) Meta-analysis allows extrapolation only for highly specific conditions due to numerous different experimental conditions in the used studies Metabolome Metabolic modelling (78) Precise conditions of experiments are different between labs, measurement biases possible
Combining network analysis and machine learning to predict metabolic pathways (79) Cannot be used to predict catalytic activity, only predict pathways Phenotype Deep learning methods for imagebased phenotyping, e.g. leaf counting (80) or root and shoot feature identification (81) Large datasets are required Ecosystem Ecosystem modelling, e.g. reuse of model code/reuse of eutrophication models for studying climate change (82) Partly overly simplified models; validity of outcomes must be tested; observations of species are sometimes placed at institutes of districts/regions
Assessment of reuse suitability for the selection of datasets
We have seen that in the selection of appropriate datasets for reuse, limitations and potential errors must be considered, in order to tap into the full potential of the practice, while avoiding invalid analysis. Here, we provide a checklist (Table   2 ) to aid in the selection of datasets suitable for reuse, including suggestions, suitable controls and questions to consider prior to the re-analysis of public data. 
Conclusion
In this review, challenges, limitations and risks as well as the potential of reusing public datasets were shown. Further, successful examples of data reuse were provided.
There are different steps to achieve a data sharing behaviour which complies with open data principles. As already stated above (Fig. 1) , technological progress together with changing research behaviour make open data and its reuse 1: possible, 2: easy and 3: desirable. Considering the increasing quantity of available public data, in silico analyses are starting to supersede classic 'wet lab' experiments in some areas. However, it is still difficult to determine on a case-by-case basis whether the cost-benefit analysis favours data reuse with the associated risks or the increasingly cheaper/faster sequencing. Missing metainformation, quality issues and denormalisation can prevent successful reuse of public datasets (Fig. 4 ). Fairness must be considered in both cases: ownership of the data must be acknowledged while e.g. unnecessary additional animal experiments have to be avoided if the corresponding data already exists. Next, a large number of all sorts of data is already available and enables meta-analyses. The reuse of public scientific datasets further leads to a reduction of costs and time, encourages reproducible research, enables the detection of novel information and has benefits for authors themselves. There are still some outstanding questions and challenges ( Fig. 5 ) but considering all the advantages and taking into account the limitations we still highly recommend and encourage data reuse.
• Should there be an obligation/encouragement to reuse public datasets instead of producing new ones? At which level could this be reinforced?
• Should journals require the release of all acquired data (except patient information) as a prerequisite for publication?
• How many datasets are just lost because scientists/students are moving on to other projects without publishing?
• How can the quality of the datasets be ensured?
• Who is responsible for the management of the rapidly growing databases and how can sufficient storage space/funding be realized to ensure long-term sustainability?
• Is there a suitable way for both, scientists and databases, to provide the metainformation needed for efficient and correct data reuse? 
